Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery

The Cochrane Database of Systematic Reviews
Jin-Wei ChengGuo-Cai Lu

Abstract

Trabeculectomy is performed as a treatment for glaucoma to lower intraocular pressure (IOP). The surgical procedure involves creating a channel through the wall of the eye. However scarring during wound healing can block this channel which will lead to the operation failing. Anti-vascular endothelial growth factor (VEGF) agents have been proposed to slow down healing response and scar formation. To assess the effectiveness of anti-VEGF therapies administered by subconjunctival injection for the outcome of trabeculectomy at 12 months follow-up and to examine the balance of benefit and harms when compared to any other anti-scarring agents or no additional anti-scarring agents. We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2015, Issue 10), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to November 2015), EMBASE (January 1980 to November 2015), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the...Continue Reading

References

Jun 25, 1999·The British Journal of Ophthalmology·H MietzG K Krieglstein
May 30, 2002·American Journal of Ophthalmology·Martin B WaxRobert N Weinreb
Dec 25, 2002·Microscopy Research and Technique·Jie LiRobert S Kirsner
May 15, 2003·Survey of Ophthalmology·Paul J Lama, Robert D Fechtner
Feb 10, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Robert F Diegelmann, Melissa C Evans
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jun 19, 2004·BMJ : British Medical Journal·David AtkinsUNKNOWN GRADE Working Group
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Jul 5, 2005·BMJ : British Medical Journal·Philip C MaierYngve T Falck-Ytter
Oct 20, 2005·The Cochrane Database of Systematic Reviews·M WilkinsR Wormald
Feb 21, 2006·The British Journal of Ophthalmology·H A Quigley, A T Broman
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Feb 8, 2007·Ophthalmic Research·Jost B JonasFrank Schlichtenbrede
Sep 29, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Moataz E GheithMarlene R Moster
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Aug 12, 2008·Ophthalmology·Dilraj S GrewalSatinder Pal Singh Grewal
Nov 26, 2008·The Journal of Surgical Research·Philip BaoHarold Brem
Mar 28, 2009·Investigative Ophthalmology & Visual Science·Hiroyuki NomotoTetsuya Baba
Apr 8, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Erdal YuzbasiogluHalil Bahcecioglu
Apr 15, 2009·Archives of Ophthalmology·John J WroblewskiUNKNOWN Pegaptanib in Central Retinal Vein Occlusion Study Group
May 29, 2009·Investigative Ophthalmology & Visual Science·Zhongqiu LiIngeborg Stalmans
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Jul 25, 2009·Investigative Ophthalmology & Visual Science·Christophe Guibal, Gary E Baker
Feb 17, 2010·Korean Journal of Ophthalmology : KJO·Jin Young ChoiYeon-Deok Kim
Jun 12, 2010·BMJ : British Medical Journal·Adnan TufailUNKNOWN ABC Trial Investigators
Jun 25, 2010·Investigative Ophthalmology & Visual Science·Evelyn C O'NeillJonathan G Crowston
Oct 12, 2010·The Cochrane Database of Systematic Reviews·Tasanee BraithwaitePaul B Greenberg
Feb 18, 2011·The New England Journal of Medicine·Helen A Mintz-HittnerUNKNOWN BEAT-ROP Cooperative Group
Apr 30, 2011·The New England Journal of Medicine·UNKNOWN CATT Research GroupGlenn J Jaffe
May 31, 2011·American Journal of Ophthalmology·Rashmi Mathew, Keith Barton
Jun 15, 2011·Clinical & Experimental Ophthalmology·Justyna Jurkowska-DudzińskaTomasz Zarnowski
Oct 11, 2011·American Journal of Ophthalmology·Naveed NilforushanNariman Nassiri
Dec 27, 2011·Ophthalmology·John LandersPeter Watson
Jan 17, 2012·American Journal of Ophthalmology·Steven J GeddeUNKNOWN Tube versus Trabeculectomy Study Group
Mar 21, 2012·Clinical & Experimental Ophthalmology·Brian E ChuaJonathan G Crowston
Sep 14, 2012·The Cochrane Database of Systematic Reviews·Jennifer BurrAnja Tuulonen

❮ Previous
Next ❯

Citations

Jul 12, 2019·Translational Vision Science & Technology·Stéphanie HayekChristophe Baudouin
Dec 31, 2020·Pharmaceutics·Ognjenka RahićEdina Vranić

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

The Cochrane Database of Systematic Reviews
Emily CabourneJennifer R Evans
The Cochrane Database of Systematic Reviews
Christiane Al-HaddadAnn-Margret Ervin
The Cochrane Database of Systematic Reviews
John G Lawrenson, Jennifer R Evans
The Cochrane Database of Systematic Reviews
Nilo Vincent FlorCruz, Jennifer R Evans
© 2022 Meta ULC. All rights reserved